Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freson, K.
Right arrow Articles by Van Geet, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freson, K.
Right arrow Articles by Van Geet, C.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 July 2001, Vol. 98, No. 1, pp. 85-92

HEMATOPOIESIS

Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation

Kathleen Freson, Koen Devriendt, Gert Matthijs, Achiel Van Hoof, Rita De Vos, Chantal Thys, Kristien Minner, Marc F. Hoylaerts, Jos Vermylen, and Chris Van Geet

From the Center for Molecular and Vascular Biology, Center for Human Genetics, Department of Pathology and Department of Pediatrics, University of Leuven, Belgium; and Division of Hematology, A.Z. St-Jan, Brugge, Belgium.

A new mutation is described in the X-linked gene GATA1, resulting in macrothrombocytopenia and mild dyserythropoietic features but no marked anemia in a 4-generation family. The molecular basis for the observed phenotype is a substitution of glycine for aspartate in the strictly conserved codon 218 (D218G) of the amino-terminal zinc finger loop of the transcription factor GATA1. Zinc finger interaction studies demonstrated that this mutation results in a weak loss of affinity of GATA1 for its essential cofactor FOG1, whereas direct D218G-GATA1 binding to DNA was normal. The phenotypic effects of this mutation in the patients' platelets have been studied. Semiquantitative RNA analysis, normalized for beta -actin messenger RNA, showed extremely low transcription of the GATA1 target genes GPIbbeta and GPIX but also a significantly lower expression of the nondirectly GATA1-regulated Gsalpha gene, suggestive of incomplete megakaryocyte maturation. In contrast, GPIIIa expression was close to normal in agreement with its early appearance during megakaryocyte differentiation. Flow cytometric analysis of patient platelets confirmed the existence of a platelet population with abnormal size distribution and reduced GPIb complex levels but with normal GPIIIa expression. It also showed the presence of very immature platelets lacking almost all membrane glycoproteins studied (GPIbalpha , GPIbbeta , GPIIIa, GPIX, and GPV). Patients' platelets showed weak ristocetin-induced agglutination, compatible with the disturbed GPIb complex. Accordingly, electron microscopy of the patients' platelets revealed giant platelets with cytoplasmic clusters consisting of smooth endoplasmic reticulum and abnormal membrane complexes. In conclusion, GATA1 mutations can lead to isolated X-linked macrothrombocytopenia without anemia.

© 2001 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
C. Ghevaert, A. Salsmann, N. A. Watkins, E. Schaffner-Reckinger, A. Rankin, S. F. Garner, J. Stephens, G. A. Smith, N. Debili, W. Vainchenker, et al.
A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the {alpha}IIb{beta}3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia
Blood, April 1, 2008; 111(7): 3407 - 3414.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. B. Cantor, H. Iwasaki, Y. Arinobu, T. B. Moran, H. Shigematsu, M. R. Sullivan, K. Akashi, and S. H. Orkin
Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage
J. Exp. Med., March 17, 2008; 205(3): 611 - 624.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
V. Labarque, K. Freson, C. Thys, C. Wittevrongel, M. F. Hoylaerts, R. De Vos, N. Goemans, and C. Van Geet
Increased Gs signalling in platelets and impaired collagen activation, due to a defect in the dystrophin gene, result in increased blood loss during spinal surgery
Hum. Mol. Genet., February 1, 2008; 17(3): 357 - 366.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. N. Tubman, J. E. Levine, D. R. Campagna, R. Monahan-Earley, A. M. Dvorak, E. J. Neufeld, and M. D. Fleming
X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation
Blood, April 15, 2007; 109(8): 3297 - 3299.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. D. Phillips, D. P. Steensma, M. A. Pulsipher, G. J. Spangrude, and J. P. Kushner
Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria
Blood, March 15, 2007; 109(6): 2618 - 2621.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Ghinassi, M. Sanchez, F. Martelli, G. Amabile, A. M. Vannucchi, G. Migliaccio, S. H. Orkin, and A. R. Migliaccio
The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor
Blood, February 15, 2007; 109(4): 1460 - 1471.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Z. Chen, M. Hu, and R. A. Shivdasani
Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2
Blood, February 15, 2007; 109(4): 1451 - 1459.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Maeda, C. Nishiyama, T. Tokura, H. Nakano, S. Kanada, M. Nishiyama, K. Okumura, and H. Ogawa
FOG-1 represses GATA-1-dependent Fc{epsilon}RI beta-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice
Blood, July 1, 2006; 108(1): 262 - 269.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. L. Stachura, S. T. Chou, and M. J. Weiss
Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1
Blood, January 1, 2006; 107(1): 87 - 97.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Lo, L. Li, P. Gissen, H. Christensen, P. J. McKiernan, C. Ye, M. Abdelhaleem, J. A. Hayes, M. D. Williams, D. Chitayat, et al.
Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet {alpha}-granule biogenesis
Blood, December 15, 2005; 106(13): 4159 - 4166.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Kuhl, A. Atzberger, F. Iborra, B. Nieswandt, C. Porcher, and P. Vyas
GATA1-Mediated Megakaryocyte Differentiation and Growth Control Can Be Uncoupled and Mapped to Different Domains in GATA1
Mol. Cell. Biol., October 1, 2005; 25(19): 8592 - 8606.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Freson, R. De Vos, C. Wittevrongel, C. Thys, J. Defoor, L. Vanhees, J. Vermylen, K. Peerlinck, and C. Van Geet
The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure
Blood, October 1, 2005; 106(7): 2356 - 2362.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. C. Hughan, Y. Senis, D. Best, A. Thomas, J. Frampton, P. Vyas, and S. P. Watson
Selective impairment of platelet activation to collagen in the absence of GATA1
Blood, June 1, 2005; 105(11): 4369 - 4376.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ezoe, I. Matsumura, K. Gale, Y. Satoh, J. Ishikawa, M. Mizuki, S. Takahashi, N. Minegishi, K. Nakajima, M. Yamamoto, et al.
GATA Transcription Factors Inhibit Cytokine-dependent Growth and Survival of a Hematopoietic Cell Line through the Inhibition of STAT3 Activity
J. Biol. Chem., April 1, 2005; 280(13): 13163 - 13170.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Ferreira, K. Ohneda, M. Yamamoto, and S. Philipsen
GATA1 Function, a Paradigm for Transcription Factors in Hematopoiesis
Mol. Cell. Biol., February 15, 2005; 25(4): 1215 - 1227.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. K. Liew, R. J. Y. Simpson, A. H. Y. Kwan, L. A. Crofts, F. E. Loughlin, J. M. Matthews, M. Crossley, and J. P. Mackay
Zinc fingers as protein recognition motifs: Structural basis for the GATA-1/Friend of GATA interaction
PNAS, January 18, 2005; 102(3): 583 - 588.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
M. Tanaka, J. Zheng, K. Kitajima, K. Kita, H. Yoshikawa, and T. Nakano
Differentiation status dependent function of FOG-1
Genes Cells, December 1, 2004; 9(12): 1213 - 1226.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Ahmed, A. Sternberg, G. Hall, A. Thomas, O. Smith, A. O'Marcaigh, R. Wynn, R. Stevens, M. Addison, D. King, et al.
Natural history of GATA1 mutations in Down syndrome
Blood, April 1, 2004; 103(7): 2480 - 2489.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Shimizu, K. Ohneda, J. D. Engel, C. D. Trainor, and M. Yamamoto
Transgenic rescue of GATA-1-deficient mice with GATA-1 lacking a FOG-1 association site phenocopies patients with X-linked thrombocytopenia
Blood, April 1, 2004; 103(7): 2560 - 2567.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. G. Drachman
Inherited thrombocytopenia: when a low platelet count does not mean ITP
Blood, January 15, 2004; 103(2): 390 - 398.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Gurbuxani, P. Vyas, and J. D. Crispino
Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome
Blood, January 15, 2004; 103(2): 399 - 406.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Fossett, K. Hyman, K. Gajewski, S. H. Orkin, and R. A. Schulz
Combinatorial interactions of Serpent, Lozenge, and U-shaped regulate crystal cell lineage commitment during Drosophila hematopoiesis
PNAS, September 30, 2003; 100(20): 11451 - 11456.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
F. Lindeboom, N. Gillemans, A. Karis, M. Jaegle, D. Meijer, F. Grosveld, and S. Philipsen
A tissue-specific knockout reveals that Gata1 is not essential for Sertoli cell function in the mouse
Nucleic Acids Res., September 15, 2003; 31(18): 5405 - 5412.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. E. Italiano Jr, W. Bergmeier, S. Tiwari, H. Falet, J. H. Hartwig, K. M. Hoffmeister, P. Andre, D. D. Wagner, and R. A. Shivdasani
Mechanisms and implications of platelet discoid shape
Blood, June 15, 2003; 101(12): 4789 - 4796.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Mundschau, S. Gurbuxani, A. S. Gamis, M. E. Greene, R. J. Arceci, and J. D. Crispino
Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis
Blood, June 1, 2003; 101(11): 4298 - 4300.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. H. Malik, D. von Stechow, R. T. Bronson, and R. A. Shivdasani
Deletion of the GATA Domain of TRPS1 Causes an Absence of Facial Hair and Provides New Insights into the Bone Disorder in Inherited Tricho-Rhino-Phalangeal Syndromes
Mol. Cell. Biol., December 15, 2002; 22(24): 8592 - 8600.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kowalski, C. K. Liew, J. M. Matthews, D. A. Gell, M. Crossley, and J. P. Mackay
Characterization of the Conserved Interaction between GATA and FOG Family Proteins
J. Biol. Chem., September 13, 2002; 277(38): 35720 - 35729.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Yu, K. K. Niakan, M. Matsushita, G. Stamatoyannopoulos, S. H. Orkin, and W. H. Raskind
X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction
Blood, August 28, 2002; 100(6): 2040 - 2045.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Vannucchi, L. Bianchi, C. Cellai, F. Paoletti, R. A. Rana, R. Lorenzini, G. Migliaccio, and A. R. Migliaccio
Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1low mice)
Blood, July 30, 2002; 100(4): 1123 - 1132.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. Freson, G. Matthijs, C. Thys, P. Marien, M. F. Hoylaerts, J. Vermylen, and C. Van Geet
Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation
Hum. Mol. Genet., January 1, 2002; 11(2): 147 - 152.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. A. Shivdasani
Molecular and Transcriptional Regulation of Megakaryocyte Differentiation
Stem Cells, September 1, 2001; 19(5): 397 - 407.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Newton, J. Mackay, and M. Crossley
The N-terminal Zinc Finger of the Erythroid Transcription Factor GATA-1 Binds GATC Motifs in DNA
J. Biol. Chem., September 14, 2001; 276(38): 35794 - 35801.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020